Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 187
Filter
2.
Neuropathol Appl Neurobiol ; 46(2): 111-124, 2020 02.
Article in English | MEDLINE | ID: mdl-31179566

ABSTRACT

AIMS: Alterations in microenvironments are a hallmark of cancer, and these alterations in germinomas are of particular significance. Germinoma, the most common subtype of central nervous system germ cell tumours, often exhibits massive immune cell infiltration intermingled with tumour cells. The role of these immune cells in germinoma, however, remains unknown. METHODS: We investigated the cellular constituents of immune microenvironments and their clinical impacts on prognosis in 100 germinoma cases. RESULTS: Patients with germinomas lower in tumour cell content (i.e. higher immune cell infiltration) had a significantly longer progression-free survival time than those with higher tumour cell contents (P = 0.03). Transcriptome analyses and RNA in-situ hybridization indicated that infiltrating immune cells comprised a wide variety of cell types, including lymphocytes and myelocyte-lineage cells. High expression of CD4 was significantly associated with good prognosis, whereas elevated nitric oxide synthase 2 was associated with poor prognosis. PD1 (PDCD1) was expressed by immune cells present in most germinomas (93.8%), and PD-L1 (CD274) expression was found in tumour cells in the majority of germinomas examined (73.5%). CONCLUSIONS: The collective data strongly suggest that infiltrating immune cells play an important role in predicting treatment response. Further investigation should lead to additional categorization of germinoma to safely reduce treatment intensity depending on tumour/immune cell balance and to develop possible future immunotherapies.


Subject(s)
Brain Neoplasms/diagnosis , Brain Neoplasms/immunology , Cell Lineage/immunology , Germinoma/diagnosis , Germinoma/immunology , Brain Neoplasms/metabolism , Gene Expression Profiling , Germinoma/metabolism , Humans , Prognosis , Transcriptome , Tumor Microenvironment/immunology
3.
J Nutr Health Aging ; 20(4): 453-7, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26999247

ABSTRACT

OBJECTIVES: Older patients receiving home medical care often have declining functional status and multiple disease conditions. It is important to identify the risk factors for care transition events in this population in order to avoid preventable transitions. In the present study, therefore, we investigated the factors associated with discontinuation of home medical care as a potentially preventable care transition event in older patients. METHODS: Baseline data for participants in the Observational study of Nagoya Elderly with HOme MEdical (ONEHOME) study and data on the mortality, institutionalization, or hospitalisation of the study participants during a 2-year follow-up period were used. Discontinuation of home care was defined as admission to a hospital for any reason, institutionalization, or death. Univariate and multivariate Cox hazard models were used to assess the association of each of the factors with the discontinuation of home care during the observational period. The covariates included in the multivariate analysis were those significantly associated with the discontinuation of home care at the level of P<0.05 in the univariate analysis. RESULTS: The univariate Cox hazard model revealed that a low hemoglobin level (< 11g/dL), low serum albumin level (< 3g/dL), higher Charlson Comorbidity Index score, and low Mini Nutritional Assessment Short Form score (< 7) were significantly associated with the discontinuation of home care. A multivariate Cox hazard model including these four factors demonstrated that all four were independently associated with home-care discontinuation. CONCLUSIONS: The present results demonstrated that anemia, hypoalbuminemia, malnourishment, and the presence of serious comorbidities were associated with the discontinuation of home medical care among low-functioning older patients.


Subject(s)
Geriatric Assessment , Home Care Services/statistics & numerical data , Hospitalization/statistics & numerical data , Aged , Aged, 80 and over , Comorbidity , Female , Follow-Up Studies , Hemoglobins/analysis , Humans , Male , Nutrition Assessment , Proportional Hazards Models , Risk Factors , Serum Albumin/analysis
4.
Med Humanit ; 35(1): 39-42, 2009 Jun.
Article in English | MEDLINE | ID: mdl-23674631

ABSTRACT

The ageing population means that dementia is a serious social problem in Japan. Attitudes toward ageing in Japan are increasingly negative, and views of life and death among older people vary. Numerous ethical problems exist in the medical treatment of dementia. Amidst such conditions, it is important and beneficial to examine films that depict demented patients and to consider the issues raised by these films. Through film we see many aspects of a country and its times: culture and ideology, morality and religion, medical treatments, views on life and death, social conditions and what issues are viewed as problems. The best films both entertain audiences and provide viewers with opportunities to think about social problems. In the past 30 years, 10 films about dementia had been made in Japan and two of these-The Twilight Years (Kôkotsu no hito) and Memories of Tomorrow (Ashita no kioku) are the main focus of this paper. In our analysis we consider three points: how the patients are informed of their disease, the characters' wishes for death, and terminal medical care.

5.
J Med Ethics ; 34(12): 858-62, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19043109

ABSTRACT

Clinical ethics support, including ethics consultation, has become established in the field of medical practice throughout the world. This practice has been regarded as useful, most notably in the UK and the USA, in solving ethical problems encountered by both medical practitioners and those who receive medical treatment. In Japan, however, few services are available to respond to everyday clinical ethical issues, although a variety of difficult ethical problems arise daily in the medical field: termination of life support, euthanasia and questions about patient autonomy. In light of these conditions, a group of 17 volunteer educators and researchers from the area of biomedical ethics, including the authors, have formed the Clinical Ethics Support and Education Project, and began providing Japan's first small team clinical ethics consultation service in October, 2006. Members include scholars of biomedical ethics, scholars of philosophy and ethics, legal professionals and legal scholars, nurses and doctors, consisting of five women and 12 men. Consultation teams, made up of a small number of members, were organised each time a request for consultation was received. Over approximately 15 months (October 2006-December 2007), the programme received 22 consultation requests from medical practitioners and medical institutions, and three from the families of patients. In this paper, we will discuss the status of our consultation service and examples of consultation cases we have handled. In addition, we will examine the process of evaluating small team clinical ethics consultation services, as well as the strengths and weakness of such programmes.


Subject(s)
Bioethics , Ethics Consultation/organization & administration , Program Evaluation/standards , Advance Directives/ethics , Female , Humans , Japan , Male , Professional-Patient Relations/ethics , Truth Disclosure/ethics
6.
J Med Ethics ; 32(5): 303-8, 2006 May.
Article in English | MEDLINE | ID: mdl-16648283

ABSTRACT

OBJECTIVE: The purpose of this study was to demonstrate how educators involved in the teaching of bioethics to healthcare university students in Japan would cope with ethical disagreement in the classroom, and to identify factors influencing them. METHODS: A cross sectional survey was conducted using self administered questionnaires mailed to a sample of university faculty in charge of bioethics curriculum for university healthcare students. RESULTS: A total of 107 usable questionnaires were returned: a response rate of 61.5%. When facing ethical disagreement in the classroom, coping behaviour differed depending on the topic of discussion, was influenced by educators' individual clear ethical attitudes regarding the topic of discussion, and was independent of many respondents' individual and social backgrounds. Among educators, it was commonly recognised that the purpose of bioethics education was to raise the level of awareness of ethical problems, to provide information about and knowledge of those issues, to raise students' sensitivity to ethical problems, and to teach students methods of reasoning and logical argument. Yet, despite this, several respondents considered the purpose of bioethics education to be to influence students about normative ethical judgments. There was no clear relationship, however, between ways of coping with ethical disagreement and educators' sense of the purpose of bioethics education. CONCLUSIONS: This descriptive study suggests that educators involved in bioethics education for healthcare university students in Japan coped in various ways with ethical disagreement. Further research concerning ethical disagreement in educational settings is needed to provide better bioethics education for healthcare students.


Subject(s)
Bioethics/education , Students, Medical/psychology , Adaptation, Psychological , Adult , Age Distribution , Aged , Attitude to Health , Awareness , Bioethical Issues , Female , Humans , Japan , Male , Middle Aged , Sex Factors , Teaching
7.
Br J Cancer ; 86(4): 587-95, 2002 Feb 12.
Article in English | MEDLINE | ID: mdl-11870542

ABSTRACT

Mutation of the p53 gene plays a critical role in the development of cancer and response to cancer therapy. To analyze the mechanism of cancer development and to improve cancer therapy, it is important to assess which genes are downstream components of p53 in cancers, and whether the expression levels of these genes affect p53-mediated apoptosis. In this study, we transduced the wild type p53 gene along with the Apaf-1 and caspase-9 genes via adenovirus vectors into U251 and U-373MG glioma cells harbouring a mutated p53, and evaluated the degree of apoptosis. Co-induction of Apaf-1 and caspase-9 genes highly enhanced p53-mediated apoptosis in glioma cells. Induction of wild type p53 enhanced the expression levels of Bax, p21/WAF1, and Fas protein. To determine which gene is activated by wild type p53 induction and, in turn, activates Apaf-1 and caspase-9, we transduced the Bax, p21/WAF1 or Fas gene via adenovirus vector to U251 cells to achieve a similar expression level as that induced by the Adv for p53 in U251 cells. U251 cells transduced with Fas concomitant with the Apaf-1 and caspase-9 genes underwent drastic apoptosis. This suggests that induction of wild type p53 upregulates Fas, which in turn may play a role in the activation of Apaf-1 and caspase-9. These results are important for analyzing the mechanism of tumour development and for predicting the therapeutic effect of p53 replacement gene therapy in a particular patient.


Subject(s)
Apoptosis/genetics , Brain Neoplasms/genetics , Caspases/genetics , Glioma/genetics , Proteins/genetics , Receptors, Tumor Necrosis Factor , Tumor Suppressor Protein p53/genetics , Adenoviridae/genetics , Apoptotic Protease-Activating Factor 1 , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Bromodeoxyuridine , Caspase 9 , Caspases/metabolism , Cell Survival , Flow Cytometry , Gene Expression/physiology , Glioma/metabolism , Glioma/pathology , Humans , Immunoblotting , Neuropeptides/metabolism , Proteins/metabolism , Transduction, Genetic , Tumor Cells, Cultured , Tumor Suppressor Protein p53/metabolism , fas Receptor
8.
Stroke ; 32(12): 2841-4, 2001 Dec 01.
Article in English | MEDLINE | ID: mdl-11739984

ABSTRACT

BACKGROUND AND PURPOSE: We sought to examine the relationship between menstrual and reproductive factors and the risk of subarachnoid hemorrhage (SAH), using a case-control study. METHODS: Cases consisted of a consecutive series of 124 women patients with first spontaneous SAH aged 30 to 79 years and confirmed aneurysm(s) by angiography and/or CT scan. Hospital and community controls subjects were identified, matched to each case by age (+/-2 years). RESULTS: Increased SAH risk was associated with (1) earlier age at menarche (adjusted odds ratio [OR]=3.24 for age <13 years compared with age >/=13 years; 95% CI, 1.25 to 4.03) and (2) nulligravidity (adjusted OR=4.23; 95% CI, 1.05 to 7.56). No significant association of SAH risk was found with regularity of menstrual cycle, age at pregnancy, age at first birth, and number of births. The greatest risk was for the combined effect of nulligravidity and earlier menarche (<13 years) (adjusted OR=6.37; 95% CI, 1.12 to 36.2). CONCLUSIONS: The combined effect of several variables related to menstrual and reproductive history may exert a greater influence on risk of SAH compared with a single menstrual or reproductive variable.


Subject(s)
Reproductive History , Subarachnoid Hemorrhage/epidemiology , Adult , Aged , Case-Control Studies , Cerebral Angiography , Demography , Female , Gravidity , Humans , Japan/epidemiology , Menarche , Menstrual Cycle , Middle Aged , Odds Ratio , Parity , Pregnancy , Risk Assessment , Risk Factors , Subarachnoid Hemorrhage/diagnosis , Tomography, X-Ray Computed
9.
J Nutr ; 131(11): 2932-5, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11694621

ABSTRACT

Curcumin and its structurally related compounds (curcuminoids), the phenolic yellowish pigments of turmeric, display antioxidative, anticarcinogenic and hypocholesterolemic activities. In this study, we investigated the effects of dietary supplemented curcuminoids [commercial grade curcumin: a mixture of curcumin (73.4%), demethoxycurcumin (16.1%) and bisdemethoxycurcumin (10.5%)] on lipid metabolism in rats. Male Sprague-Dawley rats were assigned to three diet groups (n = 6) and fed a moderately high-fat diet (15 g soybean oil/100 g diet) for 2 wk. One diet group did not receive supplements (CONT), while the others were supplemented with 0.2 g curcuminoids/100 g diet (CUR0.2) or 1.0 g curcuminoids/100 g diet (CUR1.0). Liver triacylglycerol and cholesterol concentrations were significantly lower in CUR1.0 rats than in CONT rats. Plasma triacylglycerols in the VLDL fraction were also lower in CUR1.0 rats than in CONT rats (P < 0.05). Hepatic acyl-CoA oxidase activity of both the CUR0.2 and CUR1.0 rats was significantly higher than that of CONT rats. Furthermore, epididymal adipose tissue weight was significantly reduced with curcuminoid intake in a dose-dependent manner. These results indicate that dietary curcuminoids have lipid-lowering potency in vivo, probably due to alterations in fatty acid metabolism.


Subject(s)
Adipose Tissue/drug effects , Cholesterol/blood , Curcumin/therapeutic use , Dietary Fats/metabolism , Liver/drug effects , Phospholipids/blood , Adipose Tissue/metabolism , Analysis of Variance , Animals , Body Weight/drug effects , Cholesterol/metabolism , Curcumin/administration & dosage , Liver/metabolism , Male , Phospholipids/metabolism , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship , Triglycerides/blood
10.
J Med Ethics ; 27(5): 324-30, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11579190

ABSTRACT

OBJECTIVE: To demonstrate Japanese doctors' and nurses' attitudes towards and practices of voluntary euthanasia (VE) and to compare their attitudes and practices in this regard. DESIGN: Postal survey, conducted between October and December 1999, using a self-administered questionnaire. PARTCIPANTS: All doctor members and nurse members of the Japanese Association of Palliative Medicine. MAIN OUTCOME MEASURE: Doctors' and nurses' attitude towards and practices of VE. RESULTS: We received 366 completed questionnaires from 642 doctors surveyed (response rate, 58%) and 145 from 217 nurses surveyed (68%). A total of 54% (95% confidence interval (CI): 49-59) of the responding doctors and 53% (CI: 45-61) of the responding nurses had been asked by patients to hasten death, of whom 5% (CI: 2-8) of the former and none of the latter had taken active steps to bring about death. Although 88% (CI: 83-92) of the doctors and 85% (CI: 77-93) of the nurses answered that a patient's request to hasten death can sometimes be rational, only 33% (CI: 28-38) and 23% (CI: 16-30) respectively regarded VE as ethically right and 22% (CI: 18-36) and 15% (CI: 8-20) respectively would practise VE if it were legal. Logistic regression model analysis showed that the respondents' profession was not a statistically independent factor predicting his or her response to any question regarding attitudes towards VE. CONCLUSIONS: A minority of responding doctors and nurses thought VE was ethically or legally acceptable. There seems no significant difference in attitudes towards VE between the doctors and nurses. However, only doctors had practised VE.


Subject(s)
Attitude of Health Personnel , Attitude to Death , Euthanasia, Active, Voluntary , Euthanasia/psychology , Nurses/psychology , Physicians/psychology , Ethics, Medical , Ethics, Nursing , Humans , Japan , Palliative Care , Societies, Medical , Surveys and Questionnaires
11.
Acta Neuropathol ; 102(3): 257-63, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11585250

ABSTRACT

Cavernous malformations (CVMs) and arteriovenous malformations (AVMs) were immunostained for three smooth muscle cell (SMC)-specific protein markers (smooth muscle alpha-actin, SM1 and SM2). Smooth muscle alpha-actin, a widely used marker of SMCs, is reportedly one of the earliest proteins expressed during differentiation of SMCs and expressed in some kinds of mesoderm-derived cells. In contrast, SM1, an isoform of myosin heavy chain (MHC), is detected only in SMCs. SM2 is another MHC isoform and expressed in the contractile phenotype of SMC. All 14 intraaxial CVMs were positive for smooth muscle alpha-actin, but SM1 was detected in only three of them and SM2 was not found. Their staining pattern resembled that of normal intraparenchymal and pial veins. All 15 cerebral AVMs and 5 out of 6 extraaxial CVMs from the cavernous sinus, orbit and scalp were positive for all three markers, as were the normal cerebral arteries. The venous components of AVMs, as well as the arterial components, expressed SM2, and were different from normal veins in the brain and intraaxial CVMs. This study shows that the histological analysis using the three markers for SMC is useful to differentiate intraaxial CVM from AVM and extraaxial CVMs.


Subject(s)
Cavernous Sinus/abnormalities , Cavernous Sinus/metabolism , Intracranial Arteriovenous Malformations/metabolism , Muscle Proteins/metabolism , Muscle, Smooth/metabolism , Actins/metabolism , Adolescent , Adult , Aged , Cavernous Sinus/pathology , Cell Differentiation , Cerebral Arteries/abnormalities , Cerebral Arteries/metabolism , Cerebral Arteries/pathology , Cerebral Veins/abnormalities , Cerebral Veins/metabolism , Cerebral Veins/pathology , Female , Humans , Intracranial Arteriovenous Malformations/pathology , Male , Middle Aged , Myosin Heavy Chains/metabolism , Myosin-Light-Chain Kinase/metabolism , Orbit/abnormalities , Orbit/metabolism , Orbit/pathology , Peptide Fragments/metabolism , Scalp/abnormalities , Scalp/metabolism , Scalp/pathology
12.
Article in English | MEDLINE | ID: mdl-11563055

ABSTRACT

We have designed, synthesized, and evaluated using physical, chemical and biochemical assays various oligonucleotide N3'-->P5' phosphoramidates, as potential telomerase inhibitors. Among the prepared compounds were 2'-deoxy, 2'-hydroxy, 2'-methoxy, 2'-ribo-fluoro, and 2'-arabino-fluoro oligonucleotide phosphoramidates, as well as novel N3'-->P5' thio-phosphoramidates. The compounds demonstrated sequence specific and dose dependent activity with IC50 values in the sub-nM to pM concentration range.


Subject(s)
Amides/chemistry , Amides/pharmacology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Oligonucleotides/chemistry , Oligonucleotides/pharmacology , Phosphoric Acids/chemistry , Phosphoric Acids/pharmacology , Telomerase/antagonists & inhibitors , Amides/chemical synthesis , Enzyme Inhibitors/chemical synthesis , Humans , Inhibitory Concentration 50 , Oligonucleotides/chemical synthesis , Phosphoric Acids/chemical synthesis
13.
Neurosurgery ; 49(1): 177-86; discussion 186-7, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11440440

ABSTRACT

OBJECTIVE: Conflicting reports have been published with regard to the relationship between the efficacy of p53 gene therapy and the p53 status of gliomas. In this study, we evaluated whether U-87MG glioma cells harboring wild-type p53 and U251 and U-373MG glioma cells harboring mutated p53 demonstrate different sensitivities to p53-induced apoptosis. In addition, we tested whether transduction of Bax or caspase-9, which are downstream components of p53-induced apoptosis, can override the resistance mechanism of U-87MG cells to apoptosis. METHODS: We transduced U-87MG, U251, and U-373MG glioma cells with p53, Bax, or caspase-9 genes via adenovirus (Adv) vectors, to induce the same level of respective proteins, and evaluated the degree of apoptosis. RESULTS: U-87MG cells were highly resistant to Adv for p53 (Adv-p53)-mediated apoptosis, whereas U251 and U-373 cells underwent extensive apoptosis after Adv-p53 infection. In U-87MG cells, the elevation of Bax and Fas was not as marked as that observed in U251 and U-373MG cells after Adv-p53 infection. Endogenous expression of Bcl-XL and Bcl-2 in U-87MG cells was greater than that in U251 and U-373MG cells. U-87MG cells were more resistant to Bax-mediated apoptosis than were U251 or U-373MG cells. In contrast, U-87MG cells were more sensitive to caspase-9-mediated apoptosis than were U251 or U-373MG cells, suggesting that transduction of caspase-9 may override the resistance mechanism of U-87MG to p53-mediated apoptosis. CONCLUSION: These results demonstrate that proapoptotic function induced by p53 transduction in U-87MG cells was repressed at several steps and that induction of caspase-9 may circumvent this resistance mechanism.


Subject(s)
Apoptosis/drug effects , Caspases/pharmacology , Glioma/physiopathology , Proto-Oncogene Proteins c-bcl-2 , Tumor Suppressor Protein p53/pharmacology , Caspase 9 , Caspases/genetics , Drug Resistance , Gene Transfer Techniques , Glioma/pathology , Mutation/physiology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/pharmacology , Tumor Cells, Cultured/drug effects , Tumor Suppressor Protein p53/genetics , bcl-2-Associated X Protein
14.
Tumori ; 87(2): 104-8, 2001.
Article in English | MEDLINE | ID: mdl-11401206

ABSTRACT

We report on a patient with ependymoma who had a recurrence after long-term remission. The patient developed frontoparietal ependymoma at the age of one year and ten months. The tumor was radically removed and postoperative radiation therapy was performed. A calcified area adjacent to the area of surgical removal remained unchanged until the patient was 18 years old. The patient was healthy except for mild hemiparesis until an MRI scan performed when he was 25 years old showed regrowth of the tumor. The patient underwent surgery with additional radiation therapy and was discharged. The 23-year interval until tumor recurrence in this case is far beyond the so-called risk period of "Collins' law". Immunohistochemical study with MIB-1 and anti-p53 antibody showed a high proliferative potential of the primary and recurrent tumors and possible p53 mutation in the primary tumor. This is the first report to describe the detailed clinical course and histological features of a recurrent infantile ependymoma that progressed after Collins' risk period. It seems that follow-up of ependymoma patients after initial treatment should be performed regularly for a longer period in cases showing radiological evidence of a residual lesion.


Subject(s)
Ependymoma/therapy , Neoplasm Recurrence, Local/etiology , Supratentorial Neoplasms/therapy , Combined Modality Therapy , Ependymoma/diagnosis , Ependymoma/pathology , Humans , Infant , Male , Supratentorial Neoplasms/diagnosis , Supratentorial Neoplasms/pathology , Time Factors , Tumor Suppressor Protein p53/analysis
15.
Int J Cancer ; 93(2): 252-61, 2001 Jul 15.
Article in English | MEDLINE | ID: mdl-11410874

ABSTRACT

The p53 tumor-suppressor gene plays a critical role in radiation-induced apoptosis. Several genes, including Bax and Fas, are involved in p53-mediated apoptosis, and their over-expression enhances the degree of radiation-induced apoptosis. Apaf-1 and caspase-9 have been reported to be downstream components of p53-mediated apoptosis, suggesting that these genes play a role in radiation-induced apoptosis. In this study, we transduced U-373MG cells harboring mutant p53 with the Apaf-1 and/or caspase-9 genes via adenoviral (Adv) vectors concomitant with X-ray irradiation and evaluated the degree of apoptosis. The percentage of apoptotic cells in U-373MG cells co-infected with the Adv for Apaf-1 (Adv-APAF-1) and that for caspase-9 (Adv-Casp9) and treated with irradiation (24%) was much higher than that in cells co-infected with Adv-APAF-1 and Adv-Casp9 and not treated with irradiation (0.86%) and that in cells infected with either Adv-APAF-1 or Adv-Casp9 and treated with irradiation (2.0% or 2.6%, respectively). The apoptosis induced by co-transduction of Apaf-1 and caspase-9 and irradiation was repressed in cells that were co-infected with the Adv for Bcl-X(L) but not in cells co-infected with the Adv for Bcl-2. These results indicate that Apaf-1 and caspase-9 play a role in radiation-induced apoptosis in cancer cells harboring mutant p53. Bcl-X(L) may be critically involved in the radioresistance of cancer cells by repressing Apaf-1- and caspase-9-mediated apoptosis. Expression of Apaf-1 and caspase-9 in tumors may be an important determinant of the therapeutic effect of irradiation in cancer treatment.


Subject(s)
Apoptosis , Caspases/metabolism , Glioma/pathology , Proteins/metabolism , Adenoviridae/genetics , Apoptosis/genetics , Apoptotic Protease-Activating Factor 1 , Caspase 9 , Caspases/genetics , Genetic Vectors , Glioma/enzymology , Glioma/metabolism , Humans , Proteins/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Transduction, Genetic , Tumor Cells, Cultured/pathology , Tumor Cells, Cultured/radiation effects , bcl-X Protein
16.
Jpn J Cancer Res ; 92(4): 467-74, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11346470

ABSTRACT

Several apoptosis-related genes have been reported to be involved in chemotherapy-induced apoptosis in cancers. An assessment of the relationship between expression of those genes and the degree of chemotherapy-induced apoptosis may be useful in improving the efficacy of cancer therapy. We transduced Apaf-1 (apoptotic protease-activating factor-1) and caspase-9 into U-373MG glioma cells using adenovirus (Adv) vectors in the presence of etoposide and evaluated the degree of apoptosis. The degree of apoptosis in etoposide-treated U-373MG cells infected with Adv for Apaf-1 (Adv-APAF1) was higher (27%) than that in cells infected with control Adv (14%), that in cells infected with Adv for caspase-9 (Adv-Casp9) was higher (34%) than that in cells infected with Adv-APAF1, and that in cells infected with both Adv-APAF1 and Adv-Casp9 was the highest (41%). Treatment with etoposide increased expression of p53 and decreased expression of Bcl-X(L) in U-373MG cells which harbored mutant p53. These results indicate that the expression of Apaf-1 and caspase-9 may be important determinants in predicting the sensitivity of cancers to chemotherapy. Adv-mediated co-transduction of Apaf-1 and caspase-9 should render cancer cells highly sensitive to chemotherapy.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Caspases/genetics , Etoposide/pharmacology , Glioma/genetics , Glioma/pathology , Proteins/genetics , Adenoviridae/genetics , Apoptosis/genetics , Apoptotic Protease-Activating Factor 1 , Caspase 9 , Caspases/biosynthesis , Caspases/physiology , Genes, p53 , Genetic Vectors/genetics , Glioma/enzymology , Glioma/therapy , Humans , Mutation , Protein Biosynthesis , Proteins/physiology , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , Transduction, Genetic/methods , Tumor Cells, Cultured , Tumor Suppressor Protein p53/biosynthesis , Tumor Suppressor Protein p53/genetics , bcl-X Protein
17.
Am J Kidney Dis ; 37(6): 1216-22, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11382691

ABSTRACT

The aim of this study is to show the preferences of Japanese dialysis patients for receiving cardiopulmonary resuscitation (CPR) in their current health status, if they were severely demented, or if they had terminal cancer and to determine their desires about continuing dialysis if they were severely demented or had terminal cancer. A questionnaire survey including the three scenarios was administered to 450 dialysis patients in 15 hospitals in JAPAN: Three hundred ninety-eight patients completed the questionnaires for a response rate of 88%. The majority of responding patients were men and were undergoing hemodialysis. Only 5% of the patients had discussed their preferences regarding CPR with their physicians, and 29%, with their family members. Forty-two percent of the patients answered that they would want to receive CPR if they experienced cardiopulmonary arrest in their current health status, and 12% answered in the affirmative if they were seriously demented or had terminal cancer. Eighteen percent of the patients would want to continue dialysis if they were demented, and 45%, if they had terminal cancer. Statistical analysis showed that more patients who were working tended to want to continue dialysis if they had terminal cancer than those who were not (53% versus 37%; P < 0.014). Patients' age and preferences did not statistically correlate. Preferences of Japanese dialysis patients for CPR and dialysis vary according to differences in health status, and only a minority would want to receive CPR for cardiopulmonary arrest even in their current health status.


Subject(s)
Attitude to Health , Cardiopulmonary Resuscitation/psychology , Kidney Failure, Chronic/psychology , Renal Dialysis/psychology , Adult , Aged , Aged, 80 and over , Female , Humans , Japan , Kidney Failure, Chronic/therapy , Male , Middle Aged , Surveys and Questionnaires
18.
Int J Radiat Oncol Biol Phys ; 50(2): 525-31, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11380242

ABSTRACT

PURPOSE: Hyperthermia kills glioma cells by inducing apoptosis and is thereby an effective therapeutic modality for the treatment of malignant gliomas. However, cells harboring mutated p53 are refractory to hyperthermia-induced apoptosis. In this study, we assessed whether or not adenovirus (Adv)-mediated transduction of p53 overrides this resistant mechanism. METHODS AND MATERIALS: We transduced the p53 wild-type tumor suppressor gene into U251 glioma cells harboring mutated p53 using Adv vectors in combination with hyperthermia (43, 44.5 degrees C), and evaluated the degree of cell death and apoptosis. RESULTS: The percentage of cells that had died, as measured by trypan blue staining, among U251 cells infected with the Adv for p53 (Adv-p53) and treated with hyperthermia, was significantly higher than the percentage of cells that had died among U251 cells infected with Adv-p53 and not treated with hyperthermia, or those infected with the control Adv for dE (Adv-dE) and treated with hyperthermia. The degree of apoptosis, measured at 24 h after treatment, in hyperthermia-treated U251 cells infected with Adv-p53 (43 degrees C, 73%; 44.5 degrees C, 92%) was much higher than that infected with Adv-p53 (41%), or that infected with control Adv-dE and treated with hyperthermia (43 degrees C, 1.3%; 44.5 degrees C, 19%). Treatment with combined hyperthermia and Adv-p53 infection induced cleavage of caspase-3 in U251 cells. CONCLUSION: These results indicate that Adv-mediated transduction of p53 would render glioma cells highly sensitive to hyperthermia.


Subject(s)
Apoptosis/physiology , Genes, p53/genetics , Genetic Therapy , Glioma/therapy , Hyperthermia, Induced , Adenoviridae/genetics , Apoptosis/genetics , Combined Modality Therapy , DNA Fragmentation , Glioma/genetics , Glioma/pathology , Humans , Mutation , Transduction, Genetic , Tumor Cells, Cultured , Tumor Suppressor Protein p53/biosynthesis , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/physiology
19.
Genes Cells ; 6(3): 237-47, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11260267

ABSTRACT

BACKGROUND: Mouse imprinted gene Peg3 encodes a large C2H2 type zinc finger protein with unique characteristics. Peg3 knockout mice were found to show an impairment in maternal behaviour of the adult female. Mouse Peg3 is located on the proximal region of chromosome 7 which is syntenic to the long arm of human chromosome 19. It has been reported that a loss of heterozygosity (LOH) of chromosome 19q occurs frequently in several glioma types. RESULTS: We isolated human PEG3 cDNA. Both human and mouse PEG3 were strongly expressed in the adult brain and the Peg3 protein was localized in the nuclei of both neurones and glial cells. A significant decrease in PEG3 expression was more commonly observed in glioma cell lines as compared with that in primary cultures of astrocytes. Transfection of PEG3 cDNA in a glioma cell line resulted in a loss of tumorigenicity in nude mice. CONCLUSIONS: The human PEG3 gene is a paternally expressed imprinted gene. Introduction of PEG3 cDNA into the glioma cells suggests that human PEG3 protein functions as a tumour suppressor. Human PEG3 is located on 19q13.4 and is one of the candidates for tumour suppressor genes that are predicted to be sited in gliomas.


Subject(s)
Genes, Tumor Suppressor , Genomic Imprinting/genetics , Glioma/genetics , Protein Kinases , Proteins/genetics , Transcription Factors , 5' Untranslated Regions/genetics , Alternative Splicing/genetics , Animals , Brain/growth & development , Brain/metabolism , Brain Neoplasms/chemistry , Brain Neoplasms/genetics , Brain Neoplasms/pathology , Female , Glioma/chemistry , Glioma/pathology , Humans , Kruppel-Like Transcription Factors , Male , Mice , Mice, Inbred BALB C , Mice, Knockout , Mice, Nude , Middle Aged , Molecular Sequence Data , Protein Biosynthesis , Proteins/metabolism , Proteins/physiology , Tumor Cells, Cultured
20.
Neurol Res ; 23(8): 869-74, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11760880

ABSTRACT

Although radiation injuries to the brain are well documented, immediate early histological changes in the brain remain to be defined. The present study characterizes glial injury provoked in adult rat white matter within 24 h after a single irradiation of the whole brain (10 or 20 Gray). Irradiated brains were histologically and histochemically analyzed. TUNEL-positive cells exhibiting apoptotic morphology were counted in five representative regions of the white matter. Glial cell death was further evaluated by glial cell density 24 h after irradiation, which induced both dose (p < 0.0001)- and time- (p < 0.0001) dependent apoptosis in these cells. The overall apoptotic rate in the white matter peaked within 8 h after irradiation. Total glial cell density decreased significantly in the white matter 24 h after irradiation. TUNEL-positive cells were immunohistochemically negative for GFAP, a marker for astrocytes, but positive for CNP, a marker for oligodendrocytes. The apoptotic rate was highest in the external capsule (p < 0.0001), followed by the fimbria and genu of the corpus callosum (p < 0.0001). The rates were lowest in the internal capsule and cerebellum. These data indicated that brain irradiation induces rapid apoptotic depletion of the oligodendroglial population, which may participate in the development of radiation-induced pathological conditions.


Subject(s)
Apoptosis/radiation effects , Oligodendroglia/cytology , Oligodendroglia/radiation effects , Radiation Injuries, Experimental/pathology , Age Factors , Animals , Brain/pathology , Brain/radiation effects , Cell Count , Dose Fractionation, Radiation , Dose-Response Relationship, Radiation , In Situ Nick-End Labeling , Male , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL